Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | NFYC |
| Upstream (Parents) |
|---|
| (<<) JUND → NFYC |
| (<<) SP1 → NFYC |
| (<<) RXRB → NFYC |
| (<<) CLOCK → NFYC |
| Downstream (Children) |
|---|
| NFYC → TFAP2A (>>) |
| NFYC → STAT1 (>>) |
| NFYC → TP53 (>>) |
| NFYC → IRF6 (>>) |
| NFYC → BHLHE40 (>>) |
| NFYC → TFAP2C (>>) |
| NFYC → ZNF643 (>>) |
| NFYC → CITED2 (>>) |
| NFYC → FOXO3 (>>) |
| NFYC → FOXJ3 (>>) |
| NFYC → TEAD2 (>>) |
| NFYC → NR2F6 (>>) |
| NFYC → VDR (>>) |
| NFYC → FOXK2 (>>) |
| NFYC → BCL6 (>>) |
| NFYC → TAF12 (>>) |
| NFYC → HSF1 (>>) |
| NFYC → GTF2I (>>) |
| NFYC → HDX (>>) |
| NFYC → STAT3 (>>) |
| NFYC → KLF7 (>>) |
| NFYC → ATF2 (>>) |
| NFYC → KDM5B (>>) |
| NFYC → DBP (>>) |
| NFYC → ZNF167 (>>) |
| NFYC → MAX (>>) |
| NFYC → YBX1 (>>) |
| NFYC → ARNT (>>) |
| NFYC → NR2C2 (>>) |
| NFYC → RERE (>>) |
| NFYC → RELA (>>) |
